A glance at what’s happening in the world of technology.
Big data balances glaucoma risk with COVID
Research has shown that big data can assist with triaging glaucoma patients during the COVID-19 outbreak.
Scientists at the University of Michigan developed a risk stratification tool that weighed the ocular risks of delay to treatment with the threat to health of exposure to COVID-19 in clinical environments – a common reason for postponing glaucoma treatment.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
We believe that vaccine uptake will be maximised when staff are supported to make their own decisions, having been provided with clear, evidence-based information on the benefit and value of vaccinations.
